{"id":712,"date":"2017-07-17T10:15:11","date_gmt":"2017-07-17T08:15:11","guid":{"rendered":"http:\/\/blogs.tu-braunschweig.de\/pubpharm\/?p=712"},"modified":"2019-07-04T13:47:24","modified_gmt":"2019-07-04T11:47:24","slug":"top-fid-zeitschriften-2016","status":"publish","type":"post","link":"https:\/\/blog.pubpharm.de\/index.php\/2017\/07\/17\/top-fid-zeitschriften-2016\/","title":{"rendered":"TOP FID-Zeitschriften 2016"},"content":{"rendered":"

F\u00fcr 2016 liegen nun Nutzungsstatistiken der FID-Lizenzen vor. Dies sind die am h\u00e4ufigsten genutzten Top-5 Zeitschriften:<\/p>\n

    \n
  1. Drugs of the Future (Thomson Reuters)<\/li>\n
  2. Drug Development and Industrial Pharmacy (Taylor & Francis)<\/li>\n
  3. Expert Opinion on Drug Delivery (Taylor & Francis)<\/li>\n
  4. Drugs of Today (Thomson Reuters)<\/li>\n
  5. Pharmaceutical Development and Technology (Taylor & Francis)<\/li>\n<\/ol>\n

    Mittels FID-Lizenzen stellt der Fachinformationsdienst Pharmazie 51 Fachzeitschriften zur Verf\u00fcgung, die an vielen Universit\u00e4tsstandorten sonst nicht verf\u00fcgbar sind. Pharmazeutische Wissenschaftler\/innen erhalten nach einer Registrierung Volltextzugriff. N\u00e4here Informationen gibt es unter dem Reiter „Lizenzierte Zeitschriften“.<\/p>\n","protected":false},"excerpt":{"rendered":"

    F\u00fcr 2016 liegen nun Nutzungsstatistiken der FID-Lizenzen vor. Dies sind die am h\u00e4ufigsten genutzten Top-5 Zeitschriften: Drugs of the Future (Thomson Reuters) Drug Development and Industrial Pharmacy (Taylor & Francis) Expert Opinion on Drug Delivery (Taylor & Francis) Drugs of Today (Thomson Reuters) Pharmaceutical Development and Technology (Taylor & Francis) Mittels FID-Lizenzen stellt der Fachinformationsdienst […]<\/p>\n","protected":false},"author":182,"featured_media":1409,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-712","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fid-lizenzen"],"_links":{"self":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/712","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/users\/182"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/comments?post=712"}],"version-history":[{"count":1,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/712\/revisions"}],"predecessor-version":[{"id":1410,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/posts\/712\/revisions\/1410"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media\/1409"}],"wp:attachment":[{"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/media?parent=712"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/categories?post=712"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.pubpharm.de\/index.php\/wp-json\/wp\/v2\/tags?post=712"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}